63
Participants
Start Date
March 30, 2016
Primary Completion Date
April 2, 2018
Study Completion Date
June 20, 2018
R:GEN Selective Retina Therapy
Selective Retina Therapy (SRT) is the treatment method using innovative laser technology with the wavelength absorbed by melanosomes such as laser photocoagulation, but due to short pulse width (1.7 µs) with 100 Hz repetition rate, Retinal Pigment Epithelium (RPE) cells may be destroyed only through the generation of microbubble around melanosomes (photomechanical action), and no thermal damage of normal cells or tissues may occur in the surrounding tissues. SRT influences the RPE wound healing, including migration and proliferation of RPE cells, which treats CSC in the mechanism of recovering RPE. Once RPE is recovered, the sub-retinal fluid may be pumped out and retinal function again recovered. Moreover, previous studies showed that SRT may stimulate a moderate increase of activated metalloproteinase (MMP), leading to the improvement of Bruch's membrane's transport property.
Seoul National University Bundang Hospital, Seongnam-si
Korea University Anam hospital, Seoul
Nune Eye Hospital, Seoul
Seoul National University Hospital, Seoul
The Catholic University of Korea Seoul ST.Mary's Hospital, Seoul
The Catholic University of Korea Yeouido St.Mary's Hospital, Seoul
Lead Sponsor
LUTRONIC Corporation
INDUSTRY